FDA Eyes Manufacturing Innovation to Boost Drug Development

May 2, 2004
Jill Wechsler
Jill Wechsler

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

Pharmaceutical Technology, Pharmaceutical Technology-05-02-2004, Volume 28, Issue 5

New technologies, along with changes in FDA oversight, may provide a critical path to make more new drugs available more quickly to patients.